Document And Entity Information
Document And Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2017 | Mar. 02, 2018 | Jun. 30, 2017 | |
Document Information [Line Items] | |||
Entity Registrant Name | CATASYS, INC. | ||
Entity Central Index Key | 1,136,174 | ||
Trading Symbol | cats | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Filer Category | Smaller Reporting Company | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Common Stock, Shares Outstanding (in shares) | 15,913,171 | ||
Entity Public Float | $ 21,329,027 | ||
Document Type | 10-K | ||
Document Period End Date | Dec. 31, 2017 | ||
Document Fiscal Year Focus | 2,017 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) | Dec. 31, 2017 | Dec. 31, 2016 | |
Current assets | |||
Cash and cash equivalents | $ 4,779,000 | $ 851,000 | |
Receivables, net of allowance for doubtful accounts of $476 and $0, respectively | 511,000 | 1,052,000 | |
Prepaids and other current assets | 366,000 | 420,000 | |
Total current assets | 5,656,000 | 2,323,000 | |
Long-term assets | |||
Property and equipment, net of accumulated depreciation of $1,542 and $1,620, respectively | 612,000 | 410,000 | |
Deposits and other assets | 336,000 | 371,000 | |
Total Assets | 6,604,000 | 3,104,000 | |
Current liabilities | |||
Accounts payable | 980,000 | 870,000 | |
Accrued compensation and benefits | 1,177,000 | 2,089,000 | |
Deferred revenue | 2,914,000 | 1,525,000 | |
Other accrued liabilities | 578,000 | 575,000 | |
Short term debt, related party, net of discount of $0 and $216, respectively | 9,796,000 | ||
Short term derivative liability | 8,122,000 | ||
Total current liabilities | 5,649,000 | 22,977,000 | |
Long-term liabilities | |||
Deferred rent and other long-term liabilities | 25,000 | 117,000 | |
Capital leases | 2,000 | 31,000 | |
Warrant liabilities | 30,000 | 5,307,000 | |
Total Liabilities | 5,706,000 | 28,432,000 | |
Commitments and contingencies (note 8) | |||
Stockholders' equity/(deficit) | |||
Preferred stock, $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding | 0 | 0 | |
Common stock, $0.0001 par value; 500,000,000 shares authorized; 15,889,171 and 9,214,743 shares issued and outstanding at December 31, 2017 and December 31, 2016, respectively | [1] | 2,000 | 1,000 |
Additional paid-in-capital | 294,220,000 | 254,390,000 | |
Accumulated deficit | (293,324,000) | (279,719,000) | |
Total Stockholders' equity/(deficit) | 898,000 | (25,328,000) | |
Total Liabilities and Stockholders' Equity/(Deficit) | $ 6,604,000 | $ 3,104,000 | |
[1] | The financial statements have been retroactively restated to reflect the 1-for-6 reverse-stock split that occurred on April 25, 2017. |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parentheticals) $ in Thousands | 12 Months Ended | |
Dec. 31, 2017USD ($)$ / sharesshares | Dec. 31, 2016USD ($)$ / sharesshares | |
Receivables, allowance for doubtful accounts | $ | $ 476 | $ 0 |
Property and equipment, accumulated dereciation | $ | 1,542 | 1,620 |
Short term debt, related party, discount | $ | $ 0 | $ 216 |
Preferred stock, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized (in shares) | 50,000,000 | 50,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized (in shares) | 500,000,000 | 500,000,000 |
Common stock, shares issued (in shares) | 15,889,171 | 9,214,743 |
Common stock, shares outstanding (in shares) | 15,889,171 | 9,214,743 |
Reverse Stock Split [Member] | ||
Reverse stock split | 6 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | ||
Revenues: | |||
Healthcare services revenues | $ 7,717 | $ 7,075 | |
Operating expenses | |||
Cost of healthcare services | 6,391 | 4,670 | |
General and administrative | 11,811 | 8,838 | |
Depreciation and amortization | 246 | 141 | |
Total operating expenses | 18,448 | 13,649 | |
Loss from operations | (10,731) | (6,574) | |
Other income | 132 | 106 | |
Interest expense | (3,409) | (5,354) | |
Loss on conversion of note | (1,356) | ||
Loss on issuance of common stock | (145) | ||
Loss on debt extinguishment | (2,424) | ||
Change in fair value of warrant liability | 1,778 | 2,093 | |
Change in fair value of derivative liability | 132 | (5,774) | |
Loss from operations before provision for income taxes | (13,599) | (17,927) | |
Provision for income taxes | 6 | 9 | |
Net loss | $ (13,605) | $ (17,936) | |
Basic and diluted net loss per share: (in dollars per share) | $ (0.99) | $ (1.95) | |
Basic weighted number of shares outstanding (in shares) | [1] | 13,751 | 9,179 |
[1] | The financial statements have been retroactively restated to reflect the 1-for-6 reverse-stock split that occurred on April 25, 2017. |
Consolidated Statements of Ope5
Consolidated Statements of Operations (Parentheticals) | Apr. 25, 2017 | Dec. 31, 2017 |
Reverse Stock Split [Member] | ||
Reverse stock split | 6 | 6 |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total | |
Balance (in shares) at Dec. 31, 2015 | 9,167,960 | ||||
Balance at Dec. 31, 2015 | $ 1,000 | $ 253,058,000 | $ (261,783,000) | $ (8,724,000) | |
Warrants Exercised (in shares) | 7,616 | ||||
Warrants Exercised | 46,000 | 46,000 | |||
Common stock issued for outside services (in shares) | 39,167 | ||||
Common stock issued for outside services | $ 235,000 | 235,000 | 235,000 | ||
Extinguishment of Debt | 354,000 | 354,000 | |||
Share-based Compensation Expense | 697,000 | 697,000 | |||
Net loss | (17,936,000) | $ (17,936,000) | |||
Balance (in shares) at Dec. 31, 2016 | 9,214,743 | 9,214,743 | |||
Balance at Dec. 31, 2016 | $ 1,000 | 254,390,000 | (279,719,000) | $ (25,328,000) | |
Common stock issued for outside services (in shares) | 28,985 | ||||
Common stock issued for outside services | $ 181,000 | 181,000 | 181,000 | ||
Share-based Compensation Expense | $ 465,000 | 465,000 | |||
Net loss | (13,605,000) | $ (13,605,000) | |||
Conversion of debentures | $ 2,982,994 | ||||
Conversion of debentures (in shares) | 16,509,000 | 16,509,000 | |||
Warrants issued for services | $ 252,000 | $ 252,000 | |||
Deferred salary paid in common stock (in shares) | 233,734 | ||||
Deferred salary paid in common stock | 1,204,000 | 1,204,000 | |||
Public offering (in shares) | 3,428,750 | ||||
Public offering | $ 1,000 | 16,457,000 | 16,458,000 | ||
1:6 reverse stock split (in shares) | [1] | (35) | |||
1:6 reverse stock split | [1] | 63,000 | 63,000 | ||
Warrant liability write-off | 6,879,000 | 6,879,000 | |||
Transaction Costs | (2,180,000) | $ (2,180,000) | |||
Balance (in shares) at Dec. 31, 2017 | 15,889,171 | 15,889,171 | |||
Balance at Dec. 31, 2017 | $ 2,000 | $ 294,220,000 | $ (293,324,000) | $ 898,000 | |
[1] | The financial statements have been retroactively restated to reflect the 1-for-6 reverse-stock split that occurred on April 25, 2017 |
Consolidated Statements of Sto7
Consolidated Statements of Stockholders' Equity (Deficit) (Parentheticals) | Apr. 25, 2017 | Dec. 31, 2017 |
Reverse Stock Split [Member] | ||
Reverse stock split | 6 | 6 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Operating activities: | ||
Net loss | $ (13,605) | $ (17,936) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation and amortization | 246 | 141 |
Amortization of debt discount and issuance costs included in interest expense | 3,082 | 4,651 |
Loss on debt extinguishment | 2,424 | |
Provision for doubtful accounts | 590 | 47 |
Deferred rent | (81) | (70) |
Share-based compensation expense | 465 | 697 |
Loss on conversion of convertible note | 1,356 | |
Loss on issuance of common stock, related party | 145 | |
Fair value adjustment on warrant liability | (1,778) | (2,093) |
Fair value adjustment on derivative liability | (132) | 5,774 |
Changes in current assets and liabilities: | ||
Receivables | (49) | (509) |
Prepaids and other current assets | 54 | 155 |
Deferred revenue | 1,389 | 77 |
Accounts payable and other accrued liabilities | 517 | 916 |
Net cash used by operating activities | (7,368) | (5,726) |
Investing activities: | ||
Purchases of property and equipment | (448) | (106) |
Deposits and other assets | 35 | 16 |
Net cash used by investing activities | (413) | (90) |
Financing activities: | ||
Proceeds from the issuance of common stock and warrants | 16,458 | |
Proceeds from prom issuance of bridge loan, related party | 1,300 | 300 |
Payments on convertible debenture | (4,363) | |
Proceeds from the issuance of senior promissory note, related party | 5,505 | |
Transactions costs | (1,667) | |
Capital lease obligations | (19) | (54) |
Net cash provided by financing activities | 11,709 | 5,751 |
Net increase (decrease) in cash and cash equivalents | 3,928 | (65) |
Cash and cash equivalents at beginning of period | 851 | 916 |
Cash and cash equivalents at end of period | 4,779 | 851 |
Supplemental disclosure of cash paid | ||
Interest | 106 | 149 |
Income taxes | 40 | 48 |
Supplemental disclosure of non-cash activity | ||
Common stock issued for exercise of warrants | 46 | |
Common stock issued for conversion of debt and accrued interest | 7,163 | |
Property and equipment acquired through capital leases and other financing | 34 | |
Warrants Issued for Services [Member] | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Issuance of stock and warrants | 252 | |
Supplemental disclosure of non-cash activity | ||
Issuance of stock and warrants | 252 | |
Common Stock Issued for Consulting Services [Member] | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Issuance of stock and warrants | 181 | |
Supplemental disclosure of non-cash activity | ||
Issuance of stock and warrants | 181 | |
Common Stock Issued Upon Settlement of Deferred Compensation to Officer [Member] | ||
Supplemental disclosure of non-cash activity | ||
Common stock issued upon settlement of deferred compensation to officer | $ 1,122 |
Note 1 - Summary of Significant
Note 1 - Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2017 | |
Notes to Financial Statements | |
Significant Accounting Policies [Text Block] | Note 1. Description of Business We harness proprietary big data predictive analytics, artificial intelligence and telehealth, combined with human intervention, to deliver improved member health and cost savings to health plans through integrated technology enabled treatment solutions. It is our mission to provide access to affordable and effective care, thereby improving health and reducing cost of care for people who suffer from the medical consequences of behavioral health conditions; helping these people and their families achieve and maintain better lives. Our OnTrak solution--contracted with a growing number of national and regional health plans--is designed to treat members with behavioral conditions that cause or exacerbate co-existing medical conditions. We have a unique ability to engage these members, who do not OnTrak integrates evidence-based medical and psychosocial interventions along with care coaching in a 52 50 Basis of Consolidation, Presentation, and Liquidity A t December 31, 2017, $4.8 $7,000 We could continue to incur negative cash flows and operating losses for the next twelve $618,000 We expect our current cash resources to cover expenses through at least the next twelve Our ability to fund our ongoing operations is dependent on increasing the number of members that are eligible for our solutions by signing new contracts, identifying more eligible members in existing contracts, and generating fees from existing and new contracts and the success of management ’s plan to increase revenue and continue to control expenses. We currently operate our On Trak nineteen 2018. Management ’s Plans Historically we have seen and continue to see net losses, net loss from operations, negative cash flow from operating activities, and historical working capital deficits as we continue through a period of rapid growth. These conditions raise substantial d oubt about our ability to continue as a going concern. The accompanying financial statements do not Trak first 2018. 2018. December 31, 2017, twelve All inter-company transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts in the financial statements and disclosed in the accompanying notes. Significant areas requiring the use of management estimates include expense accruals, accounts receivable allowances, accrued claims payable, the useful life of depreciable and amortizable assets, the evaluation of asset impairment, the valuation of warrant liabilities, and shared-based compensation. Actual results could differ from those estimates. Revenue Recognition Our Catasys contracts are generally designed to provide cash fees to us on a monthly basis or an upfront case rate based on enrolled members . To the extent our contracts may may not twelve Cost of Services Cost of healthcare services consists primarily of salaries related to our care coaches, outreach specialists and other staff directly involved in member care, healthcare provider claims payments, and fees charged by our third third Trak TM Share-Based Compensation Our 2017 “2017 2,333,334 243,853 2010 “2010 422A 2017 no ten three five December 31, 2017, 1,885,383 691,804 2017 Share-based compensation expense attributable to continuing operations were $ 465,000 $697,000 December 31, 2017 2016, Stock Options – Employees and Directors We measure and recognize compensation expense for all share-based payment awards made to employees and directors based on estimated fair values on the date of grant. We estimate the fair value of share-based payment awards using the Black -Scholes option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the consolidated statements of operations. We recognize forfeitures when they occur. There were 1.7 for the year ended December 31, 2017 no December 31, 2016. The stock compensation expense was calculated using the Black-Scholes model based on upon the following assumptions: December 31, 2017 Expected volatility 102.90% Risk-free interest rate 2.23 - 2.46% Weighted average expected lives in years 10.0 Expected dividend 0% Stock Options and Warrants – Non-employees We account for the issuance of stock options and warrants for services from non-employees by estimating the fair value of stock options and warrants issued using the Black-Scholes pricing model. This model’s calculations incorporate the exercise price, the market price of shares on grant date, the weighted average risk-free interest rate, expected life of the option or warrant, expected volatility of our stock and expected dividends. For options and w arrants issued as compensation to non-employees for services that are fully vested and non-forfeitable at the time of issuance, the estimated value is recorded in equity and expensed when the services are performed and benefit is received. For unvested shares, the change in fair value during the period is recognized in expense using the graded vesting method. From time to time, we have retained terminated employees as part-time consultants upon their departure from the company. Because the employees continue to provide services to us, their options continue to vest in accordance with the original terms. Due to the change in classification of the option awards, the options are considered modified at the date of termination. The modifications are treated as exchanges of the original awards in return for the issuance of new awards. At the date of termination, the unvested options are no not no twelve December 31, 2017 2016, Income Taxes We account for income taxes using the liability method in accordance with Accounting Standards Committee (“ASC”) 740 no Basic and Diluted Income ( Loss ) per Share Basic income (loss) per share is computed by dividing the net income (loss) to common stockholders for the period by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of shares of common stock and dilutive common equivalent shares outstanding during the period. Common equivalent shares, consisting of approximately 3,896,911 1,557,369 December 31, 2017 2016, Cash and Cash Equivalents We consider all highly l iquid investments with an original maturity of three may December 31, 2017, $4.6 Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between ( 1 market participant assumptions developed based on market data obtained from independent sources (observable inputs) and ( 2 three three Level Input: Input Definition: Level I Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date. Level II Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date. Level III Unobservable inputs that reflect management ’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The following table s summarize fair value measurements by level at December 31, 2017 2016, Balance at December 31, 201 6 (Amounts in thousands ) Level I Level I I Level II I Tota l Certificates of deposi t 106 - - 106 Total assets 106 - - 106 Warrant liabilitie s - - 5,307 5,307 Derivative Liabilit y 8,122 8,122 Total liabilities - - 13,429 13,429 Balance at December 31, 201 7 (Amounts in thousands ) Level I Level I I Level II I Tota l Certificates of deposi t 71 - - 71 Total assets 71 - - 71 Warrant liabilitie s - - 30 30 Derivative Liabilit y - - Total liabilities - - 30 30 Financial instruments classified as Level III in the fair value hierarchy as of December 31, 2017, Warrant Liabilities The following table summarizes our fair value measurements using significant Level III inputs, and changes therein , for the years ended December 31, 2017 2016: Level II I Level II I Warrant Derivative (Dollars in thousands ) Liabilitie s (Dollars in thousands ) Liabilitie s Balance as of December 31, 2015 $ 509 Balance as of December 31, 2015 $ 2,348 Issuance (exercise) of warrants, net 4,821 Issuance (exercise) of derivatives, net - Change in fair value (2,093 ) Change in fair value 5,774 Exchange of warrants 2,070 Debt Modification - Balance as of December 31, 2016 $ 5,307 Balance as of December 31, 2016 $ 8,122 Issuance (exercise) of warrants, net 2,674 Issuance (exercise) of derivatives, net - Change in fair value (1,778 ) Change in fair value (132 ) Write off of warrants (6,173 ) Write off of derivative liability (7,990 ) Balance as of December 31, 2017 $ 30 Balance as of December 31, 2017 $ - Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from two seven which is typically five seven Capital Leases Assets held under capital leases include computer equipment, and are recorded at the lower of the net present value of the minimum lease payments or the fair value of the leased asset at the inception of the lease. Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets. All lease agreements meet at least one four 840 Warrant Liabilities In March 2016, $900,000 $900,000 “March 2016 March 2016 30 8% 12% five 75,000 $2.82 “March 2016 106,818 March 2016 $1.98 May 2016 In April 2016, March 2016 $400,000, $1.3 “April five 33,333 $2.82 “April 2016 47,475 April 2016 $1.98 May 2016 In May 2016, April 2016 $405,000, $1.7 “May five 51,136 $1.98 “May 2016 In June 2016, May 2016 $480,000, $2.2 “June 2016 five 60,606 $1.98 “June 2016 In July 2016, June 2016 $570,000, $2.8 “July 2016 five 71,970 $1.98 “July 2016 . In August 2016, three $2.8 “August 2016 five 145,833 $6.60 “August 2016 The August 2016 August 2016 August 2016 August 2016 In addition, in August 2016, July 2016 $2.8 August 2016 338,005 $1.98 498,927 $6.60 August 2016 In December 2016, August 2016 $5.6 8% March 15, 2017 ( five ’s common stock in amount equal to forty 40% 337,139 $6.60 “December 2016 April 2017, The December 2016 December 2016 December 2016 December 2016 December 2016 In December 2016, $300,000 8% March 31, 2017 ( “December 2016 five ’s common stock in an amount equal to seventy-five 75% 44,118 December 2016 $5.10 March 2017, December 2016 The Shamus Warrants include price protection provisions pursuant to which, subject to certain exempt issuances, the then exercise price of the Shamus Warrants will be adjusted if the Company issues shares of common stock at a price that is less than the then exercise price of the Shamus Warrants. Such mechanism will remain in effect until the earliest of (i) the termination date of the Shamus Warrants, (ii) such time as the Shamus Warrants are exercised or (iii) contemporaneously with the listing of our shares of common stock on a registered national securities exchange. In March 2017, April 17, 2015 July 30, 2015 $5.3 December 31, 2016. not .2 11,049 not warrants to purchase 31,167 13,258 April 26, 2017. $6.2 December 31, 2017. In January 2017, $1,300,000 8% March 31, 2017 ( “January 2017 five one hundred 100% January 2017 $5.10 “January 2017 December 2016 25% 137,883 January 2017 April 30, 2017 April 2017, $1.3 The January 2017 January 2017 January 2017 January 2017 January 2017 In connection with the Subscription Agreement described above, the number of Shamus warrants issued as part of the December 2016 75% 100% 14,706 In June 2017, 90,0000 $5.00 The warrant liabilities were calculated using the Black-Scholes model based on upon the following assumptions: December 31, 201 7 December 31, 201 6 Expected volatility 102.90 % 104.31% Risk-free interest rate 1.89 % 1.20 - 1.93% Weighted average expected lives in years 2.29 2.25 - 4.99 Expected dividend 0 % 0% For the years ended December 31, 2017 2016, $1.8 $2.1 Concentration of Credit Risk Financial instruments, which potentially subject us to a concentration of risk, include cash and accounts receivable. All of our customers are based in the United States at this time and we are not The Company maintains its cash in domestic financial institutions subject to insurance coverage issued by the Federal Deposit Insurance Corporation (FDIC). Under FDIC rules, the company is entitled to aggregate coverage as defined by the Federal regulation per account type per separate legal entity per financial institution. The Company has incurred no For the year ended December 31, 2017, four 90% four 96% For the year ended December 31, 201 6, two 78% two 81% Derivative Liability In July 2015, $3.55 12% January 18, 2016 “July 2015 July 2015 $11.40 may In October 2016, July 2015 January 18, 2016 January 18, 2017. July 2015 $1.80 July 2015 12% July 2015 April 30, 2017 April 2017, July 2015 2,385,111 Fo r the twelve December 31, 2017 2016, $132,000 $5.8 Recen tly Issued or Newly Adopted Accounting Pronouncements In April 2016, 2016 10, Revenue from Contracts with Customers (Topic 606 2016 10 2014 09, 2014 09, December 15, 2017. 2016 10 $1.8 January 1, 2018. In March 2016, 2016 09, Compensation — Stock Compensation (Topic 718 2016 09” December 15, 2016, 2016 09 not In February 2015, Consolidation (Topic 810 2015 02” 2015 02 2015 02 December 15, 2015, 2015 02 not In August 2014, 2014 15, Presentation of Financial Statements—Going Concern (Subtopic 205 40 2014 15” . 2014 15 not may no one one not 2014 15 December 15, 2016. 2014 15 not |
Note 2 - Accounts Receivable
Note 2 - Accounts Receivable | 12 Months Ended |
Dec. 31, 2017 | |
Notes to Financial Statements | |
Loans, Notes, Trade and Other Receivables Disclosure [Text Block] | Note 2 . Accounts Receivable Accounts receivables consisted of the following as of December 31, 2017 2016: December 31 , (in thousands ) 201 7 201 6 Healthcare fee s $ 985 $ 1,050 Othe r 2 2 Total receivable s $ 987 $ 1,052 Less allowance for doubtful account s (476 ) - Total receivables, ne t $ 511 $ 1,052 We use the specific identification method for recording the provision for doubtful accounts, which was $476 $0 December 31, 2017 2016. |
Note 3 - Property and Equipment
Note 3 - Property and Equipment | 12 Months Ended |
Dec. 31, 2017 | |
Notes to Financial Statements | |
Property, Plant and Equipment Disclosure [Text Block] | Note 3 . Property and Equipment Property and equipment consisted of the following as of December 31, 2017 2016: (in thousands ) 201 7 201 6 Furniture and equipmen t $ 1,836 $ 1,712 Leasehold improvement s 318 318 Total property and equipmen t 2,154 2,030 Less accumulated depreciation and amortizatio n (1,542 ) (1,620 ) Total property and equipment, ne t $ 612 $ 410 Depreciation expense was $246,000 $141,000 December 31, 2017 2016, |
Note 4 - Capital Lease Obligati
Note 4 - Capital Lease Obligations | 12 Months Ended |
Dec. 31, 2017 | |
Notes to Financial Statements | |
Capital Leases in Financial Statements of Lessee Disclosure [Text Block] | Note 4 . Capital Lease Obligations We lease certain computer equipment under agreements entered into during 2016 $86,000 $103,000 December 31, 2017 2016, December 31, 2017 2016 $59,000 $47,000, The future minimum lease payments required under the capital leases and the present values of the net minimum lease payments as of December 31, 2017, (in thousands ) Amoun t Year ending December 31 , 201 8 $ 34 201 9 2 Total minimum lease payment s 36 Less amounts representing interes t (5 ) Capital lease obligations, net of interes t 31 Less current maturities of capital lease obligation s (29 ) Long-term capital lease obligation s $ 2 |
Note 5 - Income Taxes
Note 5 - Income Taxes | 12 Months Ended |
Dec. 31, 2017 | |
Notes to Financial Statements | |
Income Tax Disclosure [Text Block] | Note 5 . Income Taxes As of December 31, 201 7, $235 $222 2025, 2017. seven The primary components of temporary differences which give rise to our net deferred tax assets are as follows: 201 7 201 6 (in thousands ) Federal, state and foreign net operating losse s $ 53,911 $ 78,466 Stock based compensatio n 4,937 7,429 Accrued liabilitie s 157 664 Other temporary difference s 3,426 4,894 Valuation allowanc e (62,431 ) (91,453 ) $ - $ - The Company has provided a valuation allowance in full on its net deferred tax assets in accordance with ASC 740 not 740. federal tax code, which could further limit the Company's ability to realize its deferred tax assets. A reconciliation between the statutory federal income tax rate and the effective income tax rate for the years ended December 31, 201 7 201 6 Federal statutory rat e -34.0 % -34.0 % State taxes, net of federal benefi t -5.5 % 26.2 % Non-deductible goodwil l 0.0 % 0.0 % ISO / ESP P 0.3 % 0.2 % Othe r 249.6 % -0.5 % Change in valuation allowanc e -210.4 % 8.0 % Tax provisio n 0.0 % -0.1 % Current accounting rules require that companies recognize in the consolidated financial statements the impact of a tax position, if that position is more likely than not 2012 2016. 2012. no December 31, 2017, no The Company has adopted guidance issued by the FASB that clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold of more likely than not not There were no December 31, 2017 2016, no 2011, 2012. |
Note 6 - Common Stock
Note 6 - Common Stock | 12 Months Ended |
Dec. 31, 2017 | |
Notes to Financial Statements | |
Stockholders' Equity Note Disclosure [Text Block] | Note 6 . Common Stock In April 2017, ’s securities. Pursuant to the underwriting agreement, we agreed to issue and sell an aggregate 3,125,000 $4.80 $4.464 April 28, 2017. $15.0 Pursuant to the underwriting agreement with Joseph Gunnar, we granted the underwriters a 45 468,750 May, 303,750 $1.5 In connection with the public offering, our common stock began trading on the NASDAQ Capital Market (“NASDAQ”) under the symbol “CATS” beginning on April 26, 2017. In April 2017, including Acuitas and Shamus exercised their option to convert their convertible debentures and received 2,982,994 $1.4 twelve December 31, 2017. In April 2017, $1.1 233,734 $83,807 In April 2017, 1 6 of our common stock, pursuant to which each six one not No All stock options and warrants to purchase common stock outstanding and our common stock reserved for issuance under our equity incentive plans immediately prior to the reverse stock split were appropriately adjusted by dividing the number of affected shares of common stock by six six During 2017 2016, 28,985 39,167 $181,000 $235,000, |
Note 7 - Share-based Compensati
Note 7 - Share-based Compensation | 12 Months Ended |
Dec. 31, 2017 | |
Notes to Financial Statements | |
Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | Note 7 . Share-based Compensation The 2017 provides for the issuance of up to 2,333,334 243,853 2010 422A 2017 We grant all such share-based compensation awards at no no ten three five December 31, 2017, 1,885,383 691,804 $465,000 $697,000 December 31, 2017 2016, Stock Options – Employees and Directors There were 1,674,864 2017 no 2016. The estimated weighted average fair value of the options granted during 2017 $2.32 Stock option activity for employee and director grants is summarized as follows: Weighted Avg. Aggregate Shares Exercise Price Intrinsic Value Balance, December 31, 2015 245,213 $ 39.06 $ - 2016 Granted - - Cancelled/Expired (1,167 ) 67.86 Balance, December 31, 2016 244,046 $ 38.94 $ - 2017 Granted 1,674,864 7.50 Cancelled/Expired (33,527 ) 14.54 Balance, December 31, 2017 1,885,383 $ 11.46 $ - Exercisable at December 31, 2017 306,612 $ 31.49 $ - The weighted average remaining contractual life and weighted average exercise price of options outstanding as of December 31, 2017 Options Outstandin g Options Exercisabl e Range of Exercise Price s Share s Weighted Average Remaining Life (yrs ) Weighted Average Pric e Share s Weighted Average Pric e $0.00 to $110.0 0 1,883,839 8.64 $ 10.66 305,068 $ 26.82 $110.01 to to $1,500.0 0 1,544 1.03 953.39 1,544 953.39 1,885,383 8.63 $ 11.43 306,612 $ 31.49 Share-based compensation expense relating to stock options granted to employees and directors was $465,000 $697,000 December 31, 2017 2016, As of December 31, 2017, $4.7 4.23 Stock Options and Warrants – Non-employees In addition to stock options granted under the Plan, we have also granted options and warrants to purchase our common stock to certain non-employees that have been approved by our Board of Directors. W arrants granted to non-employees outstanding as of December 31, 2017 2016, December 31, 201 7 Descriptio n Share s Weighted Average Exercise Pric e Warrants issued in connection with equity offerin g 156,250 $ 6.00 Warrants issued in connection with debt agreement s 451,918 4.51 Warrants issued for service s 90,000 5.00 698,168 $ 4.91 December 31, 201 6 Descriptio n Share s Weighted Average Exercise Pric e Warrants issued in connection with equity offerin g - $ - Warrants issued in connection with debt agreement s 1,026,017 4.80 Warrants issued for service s - - 1,026,017 $ 4.80 |
Note 8 - Commitments and Contin
Note 8 - Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2017 | |
Notes to Financial Statements | |
Commitments and Contingencies Disclosure [Text Block] | Note 8 . Commitments and Contingencies Operating Lease Commitments We incurred rent expense of approximately $296,000 $296,000 December 31, 2017 2016, Our principal executive and administrative offices are located in Los Angeles, California and consist of leased office space totaling approximately 9,120 April 2019. $32,000 Rent expense is calculated using the straight-line method based on the total minimum lease payments over the initial term of the lease. Landlord tenant improvement allowances and rent expense exceeding actual rent payments are accounted for as deferred rent liability in the balance sheet and amortized on a straight- line basis over the initial term of the respective leases. Future minimum payments, by year and in the aggregate, under non-cancelable operating leases with initial or remaining terms of one December 31, 2017: (In thousands ) Yea r Amoun t 201 8 $ 387 201 9 $ 99 Legal Proceedings From time to time, we may not as of December 31, 2017. |
Note 9 - Related Party Disclosu
Note 9 - Related Party Disclosure | 12 Months Ended |
Dec. 31, 2017 | |
Notes to Financial Statements | |
Related Party Transactions Disclosure [Text Block] | Note 9 . Related Party Disclosure In January 2017, $1.3 254,904 April 2017, $1.3 In January 2017, December 2016 75% 100% 137,883 In March 2017, July 2015 not .2 warrants to purchase 31,167 April 2017. In April 2017, 181,154 $869,539 In April 2017, July 2015 $4.3 2,385,111 In April 2017, December 2016 8% $2.9 In April 2017, $1.1 233,734 $83,807 In addition, we have accounts payable outstanding with Mr. Peizer for travel and expenses of approximately $2 54,000 December 31, 2017. In January 2017, December 2016 75% 100% 14,706 In March 2017, $1.3 December 2016 276,204 |
Note 10 - Short-term Debt
Note 10 - Short-term Debt | 12 Months Ended |
Dec. 31, 2017 | |
Notes to Financial Statements | |
Debt Disclosure [Text Block] | Note 10 . Short -term Debt In March 2016, $900,000 $900,000 “March 2016 March 2016 30 8% 12% five 75,000 $2.82 “March 2016 106,818 March 2016 $1.98 May 2016 In April 2016, March 2016 $400,000, $1.3 “April five 33,33 4 $2.82 “April 2016 47,475 April 2016 $1.98 May 2016 In May 2016, April 2016 $405,000, $1.7 “May five 51,136 $1.98 “May 2016 In June 2016, May 2016 $480,000, $2.2 “June 2016 five 60,606 $1.98 “June 2016 In July 2016, June 2016 $570,000, $2.8 “July 2016 five 71,970 $1.98 “July 2016 . In August 2016, three $2.8 “August 2016 five 145,833 $6.60 “August 2016 The August 2016 August 2016 August 2016 August 2016 In addition, in August 2016, July 2016 $2.8 August 2016 338,005 $1.98 498,927 $6.60 August 2016 In December 2016, August 2016 $5.6 8% March 15, 2017 ( five ’s common stock in amount equal to forty 40% 337,139 $6.60 “December 2016 April 2017, The December 2016 December 2016 December 2016 December 2016 December 2016 In December 2016, $300,000 8% March 31, 2017 ( “December 2016 five ’s common stock in an amount equal to seventy-five 75% 44,118 December 2016 $5.10 March 2017, December 2016 The Shamus Warrants include price protection provisions pursuant to which, subject to certain exempt issuances, the then exercise price of the Shamus Warrants will be adjusted if the Company issues shares of common stock at a price that is less than the then exercise price of the Shamus Warrants. Such mechanism will remain in effect until the earliest of (i) the termination date of the Shamus Warrants, (ii) such time as the Shamus Warrants are exercised or (iii) contemporaneously with the listing of our shares of common stock on a registered national securities exchange. In March 2017, April 17, 2015 July 30, 2015 $5.3 December 31, 2016. not .2 11,049 not warrants to purchase 31,167 13,258 April 26, 2017. $6.2 December 31, 2017. In January 2017, $1,300,000 8% March 31, 2017 ( “January 2017 254,904 five ’s common stock which is equal to one hundred 100% January 2017 $5.10 “January 2017 December 2016 25% 137,883 January 2017 April 30, 2017 April 2017, $1.3 |
Note 11 - Restatement of Financ
Note 11 - Restatement of Financial Statements | 12 Months Ended |
Dec. 31, 2017 | |
Notes to Financial Statements | |
Accounting Changes and Error Corrections [Text Block] | Note 1 1 . Restatement of Financial Statements The prior year financial statements have been retroactively restated to reflect the 1 6 April 25, 2017. |
Significant Accounting Policies
Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2017 | |
Accounting Policies [Abstract] | |
Consolidation, Policy [Policy Text Block] | Basis of Consolidation, Presentation, and Liquidity A t December 31, 2017, $4.8 $7,000 We could continue to incur negative cash flows and operating losses for the next twelve $618,000 We expect our current cash resources to cover expenses through at least the next twelve Our ability to fund our ongoing operations is dependent on increasing the number of members that are eligible for our solutions by signing new contracts, identifying more eligible members in existing contracts, and generating fees from existing and new contracts and the success of management ’s plan to increase revenue and continue to control expenses. We currently operate our On Trak nineteen 2018. Management ’s Plans Historically we have seen and continue to see net losses, net loss from operations, negative cash flow from operating activities, and historical working capital deficits as we continue through a period of rapid growth. These conditions raise substantial d oubt about our ability to continue as a going concern. The accompanying financial statements do not Trak first 2018. 2018. December 31, 2017, twelve All inter-company transactions have been eliminated in consolidation. |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts in the financial statements and disclosed in the accompanying notes. Significant areas requiring the use of management estimates include expense accruals, accounts receivable allowances, accrued claims payable, the useful life of depreciable and amortizable assets, the evaluation of asset impairment, the valuation of warrant liabilities, and shared-based compensation. Actual results could differ from those estimates. |
Revenue Recognition, Policy [Policy Text Block] | Revenue Recognition Our Catasys contracts are generally designed to provide cash fees to us on a monthly basis or an upfront case rate based on enrolled members . To the extent our contracts may may not twelve |
Cost of Sales, Policy [Policy Text Block] | Cost of Services Cost of healthcare services consists primarily of salaries related to our care coaches, outreach specialists and other staff directly involved in member care, healthcare provider claims payments, and fees charged by our third third Trak TM |
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] | Share-Based Compensation Our 2017 “2017 2,333,334 243,853 2010 “2010 422A 2017 no ten three five December 31, 2017, 1,885,383 691,804 2017 Share-based compensation expense attributable to continuing operations were $ 465,000 $697,000 December 31, 2017 2016, Stock Options – Employees and Directors We measure and recognize compensation expense for all share-based payment awards made to employees and directors based on estimated fair values on the date of grant. We estimate the fair value of share-based payment awards using the Black -Scholes option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the consolidated statements of operations. We recognize forfeitures when they occur. There were 1.7 for the year ended December 31, 2017 no December 31, 2016. The stock compensation expense was calculated using the Black-Scholes model based on upon the following assumptions: December 31, 2017 Expected volatility 102.90% Risk-free interest rate 2.23 - 2.46% Weighted average expected lives in years 10.0 Expected dividend 0% Stock Options and Warrants – Non-employees We account for the issuance of stock options and warrants for services from non-employees by estimating the fair value of stock options and warrants issued using the Black-Scholes pricing model. This model’s calculations incorporate the exercise price, the market price of shares on grant date, the weighted average risk-free interest rate, expected life of the option or warrant, expected volatility of our stock and expected dividends. For options and w arrants issued as compensation to non-employees for services that are fully vested and non-forfeitable at the time of issuance, the estimated value is recorded in equity and expensed when the services are performed and benefit is received. For unvested shares, the change in fair value during the period is recognized in expense using the graded vesting method. From time to time, we have retained terminated employees as part-time consultants upon their departure from the company. Because the employees continue to provide services to us, their options continue to vest in accordance with the original terms. Due to the change in classification of the option awards, the options are considered modified at the date of termination. The modifications are treated as exchanges of the original awards in return for the issuance of new awards. At the date of termination, the unvested options are no not no twelve December 31, 2017 2016, |
Income Tax, Policy [Policy Text Block] | Income Taxes We account for income taxes using the liability method in accordance with Accounting Standards Committee (“ASC”) 740 no |
Earnings Per Share, Policy [Policy Text Block] | Basic and Diluted Income ( Loss ) per Share Basic income (loss) per share is computed by dividing the net income (loss) to common stockholders for the period by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of shares of common stock and dilutive common equivalent shares outstanding during the period. Common equivalent shares, consisting of approximately 3,896,911 1,557,369 December 31, 2017 2016, |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash and Cash Equivalents We consider all highly l iquid investments with an original maturity of three may December 31, 2017, $4.6 |
Fair Value of Financial Instruments, Policy [Policy Text Block] | Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between ( 1 market participant assumptions developed based on market data obtained from independent sources (observable inputs) and ( 2 three three Level Input: Input Definition: Level I Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date. Level II Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date. Level III Unobservable inputs that reflect management ’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The following table s summarize fair value measurements by level at December 31, 2017 2016, Balance at December 31, 201 6 (Amounts in thousands ) Level I Level I I Level II I Tota l Certificates of deposi t 106 - - 106 Total assets 106 - - 106 Warrant liabilitie s - - 5,307 5,307 Derivative Liabilit y 8,122 8,122 Total liabilities - - 13,429 13,429 Balance at December 31, 201 7 (Amounts in thousands ) Level I Level I I Level II I Tota l Certificates of deposi t 71 - - 71 Total assets 71 - - 71 Warrant liabilitie s - - 30 30 Derivative Liabilit y - - Total liabilities - - 30 30 Financial instruments classified as Level III in the fair value hierarchy as of December 31, 2017, Warrant Liabilities The following table summarizes our fair value measurements using significant Level III inputs, and changes therein , for the years ended December 31, 2017 2016: Level II I Level II I Warrant Derivative (Dollars in thousands ) Liabilitie s (Dollars in thousands ) Liabilitie s Balance as of December 31, 2015 $ 509 Balance as of December 31, 2015 $ 2,348 Issuance (exercise) of warrants, net 4,821 Issuance (exercise) of derivatives, net - Change in fair value (2,093 ) Change in fair value 5,774 Exchange of warrants 2,070 Debt Modification - Balance as of December 31, 2016 $ 5,307 Balance as of December 31, 2016 $ 8,122 Issuance (exercise) of warrants, net 2,674 Issuance (exercise) of derivatives, net - Change in fair value (1,778 ) Change in fair value (132 ) Write off of warrants (6,173 ) Write off of derivative liability (7,990 ) Balance as of December 31, 2017 $ 30 Balance as of December 31, 2017 $ - |
Property, Plant and Equipment, Policy [Policy Text Block] | Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from two seven which is typically five seven |
Lessee, Leases [Policy Text Block] | Capital Leases Assets held under capital leases include computer equipment, and are recorded at the lower of the net present value of the minimum lease payments or the fair value of the leased asset at the inception of the lease. Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets. All lease agreements meet at least one four 840 |
Warrant Liabilities, Policy [Policy Text Block] | Warrant Liabilities In March 2016, $900,000 $900,000 “March 2016 March 2016 30 8% 12% five 75,000 $2.82 “March 2016 106,818 March 2016 $1.98 May 2016 In April 2016, March 2016 $400,000, $1.3 “April five 33,333 $2.82 “April 2016 47,475 April 2016 $1.98 May 2016 In May 2016, April 2016 $405,000, $1.7 “May five 51,136 $1.98 “May 2016 In June 2016, May 2016 $480,000, $2.2 “June 2016 five 60,606 $1.98 “June 2016 In July 2016, June 2016 $570,000, $2.8 “July 2016 five 71,970 $1.98 “July 2016 . In August 2016, three $2.8 “August 2016 five 145,833 $6.60 “August 2016 The August 2016 August 2016 August 2016 August 2016 In addition, in August 2016, July 2016 $2.8 August 2016 338,005 $1.98 498,927 $6.60 August 2016 In December 2016, August 2016 $5.6 8% March 15, 2017 ( five ’s common stock in amount equal to forty 40% 337,139 $6.60 “December 2016 April 2017, The December 2016 December 2016 December 2016 December 2016 December 2016 In December 2016, $300,000 8% March 31, 2017 ( “December 2016 five ’s common stock in an amount equal to seventy-five 75% 44,118 December 2016 $5.10 March 2017, December 2016 The Shamus Warrants include price protection provisions pursuant to which, subject to certain exempt issuances, the then exercise price of the Shamus Warrants will be adjusted if the Company issues shares of common stock at a price that is less than the then exercise price of the Shamus Warrants. Such mechanism will remain in effect until the earliest of (i) the termination date of the Shamus Warrants, (ii) such time as the Shamus Warrants are exercised or (iii) contemporaneously with the listing of our shares of common stock on a registered national securities exchange. In March 2017, April 17, 2015 July 30, 2015 $5.3 December 31, 2016. not .2 11,049 not warrants to purchase 31,167 13,258 April 26, 2017. $6.2 December 31, 2017. In January 2017, $1,300,000 8% March 31, 2017 ( “January 2017 five one hundred 100% January 2017 $5.10 “January 2017 December 2016 25% 137,883 January 2017 April 30, 2017 April 2017, $1.3 The January 2017 January 2017 January 2017 January 2017 January 2017 In connection with the Subscription Agreement described above, the number of Shamus warrants issued as part of the December 2016 75% 100% 14,706 In June 2017, 90,0000 $5.00 The warrant liabilities were calculated using the Black-Scholes model based on upon the following assumptions: December 31, 201 7 December 31, 201 6 Expected volatility 102.90 % 104.31% Risk-free interest rate 1.89 % 1.20 - 1.93% Weighted average expected lives in years 2.29 2.25 - 4.99 Expected dividend 0 % 0% For the years ended December 31, 2017 2016, $1.8 $2.1 |
Concentration Risk, Credit Risk, Policy [Policy Text Block] | Concentration of Credit Risk Financial instruments, which potentially subject us to a concentration of risk, include cash and accounts receivable. All of our customers are based in the United States at this time and we are not The Company maintains its cash in domestic financial institutions subject to insurance coverage issued by the Federal Deposit Insurance Corporation (FDIC). Under FDIC rules, the company is entitled to aggregate coverage as defined by the Federal regulation per account type per separate legal entity per financial institution. The Company has incurred no For the year ended December 31, 2017, four 90% four 96% For the year ended December 31, 201 6, two 78% two 81% |
Derivatives, Policy [Policy Text Block] | Derivative Liability In July 2015, $3.55 12% January 18, 2016 “July 2015 July 2015 $11.40 may In October 2016, July 2015 January 18, 2016 January 18, 2017. July 2015 $1.80 July 2015 12% July 2015 April 30, 2017 April 2017, July 2015 2,385,111 Fo r the twelve December 31, 2017 2016, $132,000 $5.8 |
New Accounting Pronouncements, Policy [Policy Text Block] | Recen tly Issued or Newly Adopted Accounting Pronouncements In April 2016, 2016 10, Revenue from Contracts with Customers (Topic 606 2016 10 2014 09, 2014 09, December 15, 2017. 2016 10 $1.8 January 1, 2018. In March 2016, 2016 09, Compensation — Stock Compensation (Topic 718 2016 09” December 15, 2016, 2016 09 not In February 2015, Consolidation (Topic 810 2015 02” 2015 02 2015 02 December 15, 2015, 2015 02 not In August 2014, 2014 15, Presentation of Financial Statements—Going Concern (Subtopic 205 40 2014 15” . 2014 15 not may no one one not 2014 15 December 15, 2016. 2014 15 not |
Note 1 - Summary of Significa21
Note 1 - Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Notes Tables | |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | December 31, 2017 Expected volatility 102.90% Risk-free interest rate 2.23 - 2.46% Weighted average expected lives in years 10.0 Expected dividend 0% |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] | Balance at December 31, 201 6 (Amounts in thousands ) Level I Level I I Level II I Tota l Certificates of deposi t 106 - - 106 Total assets 106 - - 106 Warrant liabilitie s - - 5,307 5,307 Derivative Liabilit y 8,122 8,122 Total liabilities - - 13,429 13,429 Balance at December 31, 201 7 (Amounts in thousands ) Level I Level I I Level II I Tota l Certificates of deposi t 71 - - 71 Total assets 71 - - 71 Warrant liabilitie s - - 30 30 Derivative Liabilit y - - Total liabilities - - 30 30 |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] | Level II I Level II I Warrant Derivative (Dollars in thousands ) Liabilitie s (Dollars in thousands ) Liabilitie s Balance as of December 31, 2015 $ 509 Balance as of December 31, 2015 $ 2,348 Issuance (exercise) of warrants, net 4,821 Issuance (exercise) of derivatives, net - Change in fair value (2,093 ) Change in fair value 5,774 Exchange of warrants 2,070 Debt Modification - Balance as of December 31, 2016 $ 5,307 Balance as of December 31, 2016 $ 8,122 Issuance (exercise) of warrants, net 2,674 Issuance (exercise) of derivatives, net - Change in fair value (1,778 ) Change in fair value (132 ) Write off of warrants (6,173 ) Write off of derivative liability (7,990 ) Balance as of December 31, 2017 $ 30 Balance as of December 31, 2017 $ - |
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block] | December 31, 201 7 December 31, 201 6 Expected volatility 102.90 % 104.31% Risk-free interest rate 1.89 % 1.20 - 1.93% Weighted average expected lives in years 2.29 2.25 - 4.99 Expected dividend 0 % 0% |
Note 2 - Accounts Receivable (T
Note 2 - Accounts Receivable (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Notes Tables | |
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] | December 31 , (in thousands ) 201 7 201 6 Healthcare fee s $ 985 $ 1,050 Othe r 2 2 Total receivable s $ 987 $ 1,052 Less allowance for doubtful account s (476 ) - Total receivables, ne t $ 511 $ 1,052 |
Note 3 - Property and Equipme23
Note 3 - Property and Equipment (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Notes Tables | |
Property, Plant and Equipment [Table Text Block] | (in thousands ) 201 7 201 6 Furniture and equipmen t $ 1,836 $ 1,712 Leasehold improvement s 318 318 Total property and equipmen t 2,154 2,030 Less accumulated depreciation and amortizatio n (1,542 ) (1,620 ) Total property and equipment, ne t $ 612 $ 410 |
Note 4 - Capital Lease Obliga24
Note 4 - Capital Lease Obligations (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Notes Tables | |
Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block] | (in thousands ) Amoun t Year ending December 31 , 201 8 $ 34 201 9 2 Total minimum lease payment s 36 Less amounts representing interes t (5 ) Capital lease obligations, net of interes t 31 Less current maturities of capital lease obligation s (29 ) Long-term capital lease obligation s $ 2 |
Note 5 - Income Taxes (Tables)
Note 5 - Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Notes Tables | |
Schedule of Deferred Tax Assets and Liabilities [Table Text Block] | 201 7 201 6 (in thousands ) Federal, state and foreign net operating losse s $ 53,911 $ 78,466 Stock based compensatio n 4,937 7,429 Accrued liabilitie s 157 664 Other temporary difference s 3,426 4,894 Valuation allowanc e (62,431 ) (91,453 ) $ - $ - |
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] | 201 7 201 6 Federal statutory rat e -34.0 % -34.0 % State taxes, net of federal benefi t -5.5 % 26.2 % Non-deductible goodwil l 0.0 % 0.0 % ISO / ESP P 0.3 % 0.2 % Othe r 249.6 % -0.5 % Change in valuation allowanc e -210.4 % 8.0 % Tax provisio n 0.0 % -0.1 % |
Note 7 - Share-based Compensa26
Note 7 - Share-based Compensation (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Notes Tables | |
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] | Options Outstandin g Options Exercisabl e Range of Exercise Price s Share s Weighted Average Remaining Life (yrs ) Weighted Average Pric e Share s Weighted Average Pric e $0.00 to $110.0 0 1,883,839 8.64 $ 10.66 305,068 $ 26.82 $110.01 to to $1,500.0 0 1,544 1.03 953.39 1,544 953.39 1,885,383 8.63 $ 11.43 306,612 $ 31.49 |
Schedule of Other Share-based Compensation, Activity [Table Text Block] | December 31, 201 7 Descriptio n Share s Weighted Average Exercise Pric e Warrants issued in connection with equity offerin g 156,250 $ 6.00 Warrants issued in connection with debt agreement s 451,918 4.51 Warrants issued for service s 90,000 5.00 698,168 $ 4.91 December 31, 201 6 Descriptio n Share s Weighted Average Exercise Pric e Warrants issued in connection with equity offerin g - $ - Warrants issued in connection with debt agreement s 1,026,017 4.80 Warrants issued for service s - - 1,026,017 $ 4.80 |
Employees and Directors [Member] | |
Notes Tables | |
Share-based Compensation, Stock Options, Activity [Table Text Block] | Weighted Avg. Aggregate Shares Exercise Price Intrinsic Value Balance, December 31, 2015 245,213 $ 39.06 $ - 2016 Granted - - Cancelled/Expired (1,167 ) 67.86 Balance, December 31, 2016 244,046 $ 38.94 $ - 2017 Granted 1,674,864 7.50 Cancelled/Expired (33,527 ) 14.54 Balance, December 31, 2017 1,885,383 $ 11.46 $ - Exercisable at December 31, 2017 306,612 $ 31.49 $ - |
Note 8 - Commitments and Cont27
Note 8 - Commitments and Contingencies (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Notes Tables | |
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] | (In thousands ) Yea r Amoun t 201 8 $ 387 201 9 $ 99 |
Note 1 - Summary of Significa28
Note 1 - Summary of Significant Accounting Policies (Details Textual) | Jan. 01, 2018USD ($) | Jun. 30, 2017$ / sharesshares | Apr. 30, 2017USD ($)shares | Jan. 31, 2017USD ($)$ / sharesshares | Dec. 31, 2016USD ($)$ / sharesshares | Aug. 31, 2016USD ($)$ / sharesshares | Jul. 31, 2016USD ($)$ / sharesshares | Jun. 30, 2016USD ($)$ / sharesshares | May 31, 2016USD ($)$ / sharesshares | Apr. 30, 2016USD ($)$ / sharesshares | Mar. 31, 2016USD ($)$ / sharesshares | Dec. 31, 2017USD ($)shares | Dec. 31, 2016USD ($)$ / sharesshares | Mar. 31, 2017shares | Oct. 31, 2016$ / shares | Dec. 31, 2015USD ($) | Jul. 31, 2015USD ($)$ / shares |
Cash and Cash Equivalents, at Carrying Value | $ 851,000 | $ 4,779,000 | $ 851,000 | $ 916,000 | |||||||||||||
Working Capital Deficit | 7,000,000,000 | ||||||||||||||||
Cash Burn Rate | 618,000 | ||||||||||||||||
Share-based Compensation | $ 465,000 | $ 697,000 | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1,700,000 | 0 | |||||||||||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 3,896,911 | 1,557,369 | |||||||||||||||
Cash, Uninsured Amount | $ 4,600,000 | ||||||||||||||||
Proceeds from Related Party Debt | $ 5,505,000 | ||||||||||||||||
Warrant Liabilities, Noncurrent | 5,307,000 | 30,000 | 5,307,000 | ||||||||||||||
Repayments of Convertible Debt | 4,363,000 | ||||||||||||||||
Fair Value Adjustment of Warrants | (1,778,000) | (2,093,000) | |||||||||||||||
Derivative, Gain (Loss) on Derivative, Net | $ 132,000 | $ (5,800,000) | |||||||||||||||
Accounting Standards Update 2016-10 [Member] | Subsequent Event [Member] | |||||||||||||||||
New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Revenue | $ 1,800,000 | ||||||||||||||||
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | |||||||||||||||||
Number of Major Customers | 4 | 2 | |||||||||||||||
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Four Customers [Member] | |||||||||||||||||
Concentration Risk, Percentage | 90.00% | ||||||||||||||||
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Two Customers [Member] | |||||||||||||||||
Concentration Risk, Percentage | 78.00% | ||||||||||||||||
Accounts Receivable [Member] | Customer Concentration Risk [Member] | |||||||||||||||||
Number of Major Customers | 4 | 2 | |||||||||||||||
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Four Customers [Member] | |||||||||||||||||
Concentration Risk, Percentage | 96.00% | ||||||||||||||||
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customers [Member] | |||||||||||||||||
Concentration Risk, Percentage | 81.00% | ||||||||||||||||
Amended Warrants [Member] | |||||||||||||||||
Warrant Liabilities, Noncurrent | 5,300,000 | $ 5,300,000 | |||||||||||||||
Class of Warrant or Right, Number of Additional Securities Called by Each Warrant or Right | shares | 0.2 | ||||||||||||||||
Write-off of Warrant Liability | $ 6,200,000 | ||||||||||||||||
Warrants Not Subject to Amendment [Member] | |||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 11,049 | ||||||||||||||||
Warrants Issued for Services [Member] | |||||||||||||||||
Class of Warrant or Right, Issued During Period | shares | 90,000 | ||||||||||||||||
Warrants Issued Weighted Average Exercise Price | $ / shares | $ 5 | ||||||||||||||||
Director [Member] | |||||||||||||||||
Warrant Term | 5 years | ||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 145,833 | ||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 6.60 | ||||||||||||||||
Proceeds from Related Party Debt | $ 2,800,000 | ||||||||||||||||
Investors [Member] | |||||||||||||||||
Debt Instrument, Face Amount | $ 5,600,000 | $ 5,600,000 | |||||||||||||||
Investors [Member] | December 2016 Warrants [Member] | |||||||||||||||||
Warrant Term | 5 years | ||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 6.60 | $ 6.60 | |||||||||||||||
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion | 40.00% | 40.00% | |||||||||||||||
Class of Warrant or Right, Issued During Period | shares | 337,139 | 337,139 | |||||||||||||||
Shamus [Member] | Shamus Warrants [Member] | |||||||||||||||||
Warrant Term | 5 years | ||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 14,706 | ||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 5.10 | $ 5.10 | |||||||||||||||
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion | 100.00% | 75.00% | 75.00% | ||||||||||||||
Class of Warrant or Right, Issued During Period | shares | 44,118 | ||||||||||||||||
Acuitas [Member] | December 2016 Warrants [Member] | |||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 137,883 | ||||||||||||||||
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion | 25.00% | 25.00% | |||||||||||||||
Class of Warrant or Right, Additional Percent of Securities Called by Warrants or Rights Upon Conversion | 25.00% | ||||||||||||||||
Acuitas [Member] | Amended Warrants [Member] | |||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 31,167 | ||||||||||||||||
Acuitas [Member] | January 2017 Warrants [Member] | |||||||||||||||||
Warrant Term | 5 years | ||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 5.10 | ||||||||||||||||
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion | 100.00% | ||||||||||||||||
Acuitas [Member] | July 2015 Convertible Debenture [Member] | |||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||||
Debt Instrument, Face Amount | $ 3,550,000 | ||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ / shares | $ 1.80 | $ 11.40 | |||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | shares | 2,385,111 | ||||||||||||||||
Acuitas [Member] | |||||||||||||||||
Warrant Term | 5 years | 5 years | 5 years | 5 years | 5 years | ||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 338,005 | 71,970 | 60,606 | 51,136 | 33,333 | 75,000 | |||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 1.98 | $ 1.98 | $ 1.98 | $ 1.98 | $ 2.82 | $ 2.82 | |||||||||||
Class of Warrant or Right, Outstanding | shares | 47,475 | 106,818 | |||||||||||||||
Acuitas [Member] | Exchange of Warrants [Member] | |||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 498,927 | ||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 6.60 | ||||||||||||||||
Accredited Investor [Member] | Amended Warrants [Member] | |||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 13,258 | ||||||||||||||||
April 2016 Promissory Note [Member] | Acuitas [Member] | |||||||||||||||||
Proceeds from Issuance of Debt | $ 400,000 | ||||||||||||||||
Debt Instrument, Face Amount | 1,300,000 | ||||||||||||||||
May 2016 Promissory Note [Member] | Acuitas [Member] | |||||||||||||||||
Proceeds from Issuance of Debt | $ 405,000 | ||||||||||||||||
Debt Instrument, Face Amount | 1,700,000 | ||||||||||||||||
June 2016 Promissory Notes [Member] | Acuitas [Member] | |||||||||||||||||
Proceeds from Issuance of Debt | $ 570,000 | $ 480,000 | |||||||||||||||
Debt Instrument, Face Amount | 2,800,000 | 2,200,000 | |||||||||||||||
Senior Promissory Note [Member] | Acuitas [Member] | Exchanged Senior Demand Notes [Member] | |||||||||||||||||
Debt Instrument, Face Amount | $ 2,800,000 | $ 2,800,000 | $ 2,800,000 | ||||||||||||||
Debentures [Member] | Investors [Member] | |||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | 8.00% | 8.00% | ||||||||||||||
Warrant Term | 5 years | ||||||||||||||||
Debt Instrument, Face Amount | $ 5,600,000 | ||||||||||||||||
Debentures [Member] | Shamus [Member] | |||||||||||||||||
Warrant Term | 5 years | ||||||||||||||||
December 2016 Convertible Debenture [Member] | Investors [Member] | |||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | ||||||||||||||||
Repayments of Convertible Debt | $ 2,900,000 | ||||||||||||||||
December 2016 Convertible Debenture [Member] | Shamus [Member] | |||||||||||||||||
Proceeds from Issuance of Debt | $ 300,000 | $ 300,000 | |||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | 8.00% | |||||||||||||||
January 2017 Convertible Debenture [Member] | Acuitas [Member] | |||||||||||||||||
Proceeds from Issuance of Debt | $ 1,300,000 | ||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | ||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 254,904 | ||||||||||||||||
Class of Warrant or Right, Issued During Period | shares | 254,904 | ||||||||||||||||
Repayments of Convertible Debt | $ 1,300,000 | ||||||||||||||||
Acuitas [Member] | March 2016 Promissory Note [Member] | |||||||||||||||||
Proceeds from Issuance of Debt | $ 900,000 | ||||||||||||||||
Debt Instrument, Term | 30 days | ||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | ||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage After Maturity Date | 12.00% | ||||||||||||||||
Debt Instrument, Face Amount | $ 900,000 | ||||||||||||||||
Acuitas [Member] | April 2016 Promissory Note [Member] | |||||||||||||||||
Proceeds from Issuance of Debt | 400,000 | ||||||||||||||||
Debt Instrument, Face Amount | $ 1,300,000 | ||||||||||||||||
Acuitas [Member] | May 2016 Promissory Note [Member] | |||||||||||||||||
Proceeds from Issuance of Debt | 405,000 | ||||||||||||||||
Debt Instrument, Face Amount | $ 1,700,000 | ||||||||||||||||
Acuitas [Member] | June 2016 Promissory Notes [Member] | |||||||||||||||||
Proceeds from Issuance of Debt | 570,000 | 480,000 | |||||||||||||||
Short-term Debt | $ 2,800,000 | $ 2,200,000 | |||||||||||||||
Minimum [Member] | Furniture and Equipment [Member] | |||||||||||||||||
Property, Plant and Equipment, Useful Life | 2 years | ||||||||||||||||
Minimum [Member] | Leasehold Improvements [Member] | |||||||||||||||||
Property, Plant and Equipment, Useful Life | 5 years | ||||||||||||||||
Maximum [Member] | Furniture and Equipment [Member] | |||||||||||||||||
Property, Plant and Equipment, Useful Life | 7 years | ||||||||||||||||
Maximum [Member] | Leasehold Improvements [Member] | |||||||||||||||||
Property, Plant and Equipment, Useful Life | 7 years | ||||||||||||||||
The 2017 Stock Incentive Plan [Member] | |||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 2,333,334 | ||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 10 years | ||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 1,885,383 | ||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 691,804 | ||||||||||||||||
Share-based Compensation | $ 465,000 | $ 697,000 | |||||||||||||||
The 2017 Stock Incentive Plan [Member] | Minimum [Member] | |||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 3 years | ||||||||||||||||
The 2017 Stock Incentive Plan [Member] | Maximum [Member] | |||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 5 years | ||||||||||||||||
The 2010 Stock Incentive Plan [Member] | |||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 243,853 |
Note 1 - Summary of Significa29
Note 1 - Summary of Significant Accounting Policies - Fair Value Assumptions, Stock Options (Details) - Employee Stock Option [Member] | 12 Months Ended |
Dec. 31, 2017 | |
Expected volatility | 102.90% |
Weighted average expected lives in years (Year) | 10 years |
Expected dividend | 0.00% |
Minimum [Member] | |
Risk-free interest rate | 2.23% |
Maximum [Member] | |
Risk-free interest rate | 2.46% |
Note 1 - Summary of Significa30
Note 1 - Summary of Significant Accounting Policies - Fair Value, Assets and Liabilities Measured on a Recurring Basis (Details) - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 |
Total assets | $ 71 | $ 106 |
Warrant liabilities | 30 | 5,307 |
Derivative Liability | 8,122 | |
Total liabilities | 30 | 13,429 |
Certificates of Deposit [Member] | ||
Certificates of deposit | 71 | 106 |
Fair Value, Inputs, Level 1 [Member] | ||
Total assets | 71 | 106 |
Warrant liabilities | ||
Derivative Liability | ||
Total liabilities | ||
Fair Value, Inputs, Level 1 [Member] | Certificates of Deposit [Member] | ||
Certificates of deposit | 71 | 106 |
Fair Value, Inputs, Level 2 [Member] | ||
Total assets | ||
Warrant liabilities | ||
Derivative Liability | ||
Total liabilities | ||
Fair Value, Inputs, Level 2 [Member] | Certificates of Deposit [Member] | ||
Certificates of deposit | ||
Fair Value, Inputs, Level 3 [Member] | ||
Total assets | ||
Warrant liabilities | 30 | 5,307 |
Derivative Liability | 8,122 | |
Total liabilities | 30 | 13,429 |
Fair Value, Inputs, Level 3 [Member] | Certificates of Deposit [Member] | ||
Certificates of deposit |
Note 1 - Summary of Significa31
Note 1 - Summary of Significant Accounting Policies - Fair Value Measurements Using Significant Level III Inputs (Details) - Fair Value, Inputs, Level 3 [Member] - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Warrants [Member] | ||
Balance | $ 5,307 | $ 509 |
Issuance (exercise) of warrants, net | 2,674 | 4,821 |
Change in fair value | (1,778) | (2,093) |
Exchange of warrants | 2,070 | |
Write off of warrants | (6,173) | |
Balance | 30 | 5,307 |
Derivative Financial Instruments, Liabilities [Member] | ||
Balance | 8,122 | 2,348 |
Issuance (exercise) of warrants, net | ||
Change in fair value | (132) | 5,774 |
Exchange of warrants | ||
Write off of warrants | (7,990) | |
Balance | $ 8,122 |
Note 1 - Summary of Significa32
Note 1 - Summary of Significant Accounting Policies - Fair Value Assumptions, Warrant Liabilities (Details) - Warrant Liability [Member] | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Expected volatility | 102.90% | 104.31% |
Risk-free interest rate | 1.89% | |
Weighted average expected lives in years (Year) | 2 years 105 days | |
Expected dividend | 0.00% | 0.00% |
Minimum [Member] | ||
Risk-free interest rate | 1.20% | |
Weighted average expected lives in years (Year) | 2 years 91 days | |
Maximum [Member] | ||
Risk-free interest rate | 1.93% | |
Weighted average expected lives in years (Year) | 4 years 361 days |
Note 2 - Accounts Receivable (D
Note 2 - Accounts Receivable (Details Textual) - USD ($) | Dec. 31, 2017 | Dec. 31, 2016 |
Allowance for Doubtful Accounts Receivable | $ 476,000 | $ 0 |
Note 2 - Accounts Receivable -
Note 2 - Accounts Receivable - Summary of Accounts Receivables (Details) - USD ($) | Dec. 31, 2017 | Dec. 31, 2016 |
Receivables gross | $ 987,000 | $ 1,052,000 |
Less allowance for doubtful accounts | (476,000) | 0 |
Total receivables, net | 511,000 | 1,052,000 |
Healthcare Fees [Member] | ||
Receivables gross | 985,000 | 1,050,000 |
Other Receivable [Member] | ||
Receivables gross | $ 2,000 | $ 2,000 |
Note 3 - Property and Equipme35
Note 3 - Property and Equipment (Details Textual) - USD ($) | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Depreciation | $ 246,000 | $ 141,000 |
Note 3 - Property and Equipme36
Note 3 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 |
Furniture and equipment | $ 1,836 | $ 1,712 |
Leasehold improvements | 318 | 318 |
Total property and equipment | 2,154 | 2,030 |
Less accumulated depreciation and amortization | (1,542) | (1,620) |
Total property and equipment, net | $ 612 | $ 410 |
Note 4 - Capital Lease Obliga37
Note 4 - Capital Lease Obligations (Details Textual) - USD ($) | Dec. 31, 2017 | Dec. 31, 2016 |
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Property, Plant, and Equipment Other, Accumulated Depreciation | $ 59,000 | $ 47,000 |
Furniture and Equipment [Member] | ||
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Other Property, Plant, and Equipment, Gross | $ 86,000 | $ 103,000 |
Note 4 - Capital Lease Obliga38
Note 4 - Capital Lease Obligations - Future Minimum Lease Payments Required Under the Capital Leases (Details) - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 |
2,018 | $ 34 | |
2,019 | 2 | |
Total minimum lease payments | 36 | |
Less amounts representing interest | (5) | |
Capital lease obligations, net of interest | 31 | |
Less current maturities of capital lease obligations | (29) | |
Long-term capital lease obligations | $ 2 | $ 31 |
Note 5 - Income Taxes (Details
Note 5 - Income Taxes (Details Textual) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | $ 0 | $ 0 |
Earliest Tax Year [Member] | ||
Open Tax Year | 2,012 | |
Latest Tax Year [Member] | ||
Open Tax Year | 2,016 | |
Domestic Tax Authority [Member] | ||
Operating Loss Carryforwards | $ 235,000 | |
State and Local Jurisdiction [Member] | ||
Operating Loss Carryforwards | $ 222,000 |
Note 5 - Income Taxes - Primary
Note 5 - Income Taxes - Primary Components of Net Deferred Tax Assets (Details) - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 |
Federal, state and foreign net operating losses | $ 53,911 | $ 78,466 |
Stock based compensation | 4,937 | 7,429 |
Accrued liabilities | 157 | 664 |
Other temporary differences | 3,426 | 4,894 |
Valuation allowance | $ (62,431) | $ (91,453) |
Note 5 - Income Taxes - Reconci
Note 5 - Income Taxes - Reconciliation Between the Statutory Federal Income Tax Rate and the Effective Income Tax Rate (Details) | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Federal statutory rate | (34.00%) | (34.00%) |
State taxes, net of federal benefit | (5.50%) | 26.20% |
Non-deductible goodwill | 0.00% | 0.00% |
ISO / ESPP | 0.30% | 0.20% |
Other | 249.60% | (0.50%) |
Change in valuation allowance | (210.40%) | 8.00% |
Tax provision | 0.00% | (0.10%) |
Note 6 - Common Stock (Details
Note 6 - Common Stock (Details Textual) | Apr. 28, 2017USD ($)$ / sharesshares | Apr. 25, 2017 | May 31, 2017USD ($)shares | Apr. 30, 2017USD ($)shares | Dec. 31, 2017USD ($)shares | Dec. 31, 2016USD ($)shares |
Proceeds from Issuance of Common Stock | $ 16,458,000 | |||||
Gain (Loss) on Conversion of Debt | (1,356,000) | |||||
Gain (Loss) on Issuance of Common Stock | (145,000) | |||||
Stock Issued During Period, Value, Issued for Services | $ 181,000 | $ 235,000 | ||||
Common Stock [Member] | ||||||
Stock Issued During Period, Shares, New Issues | shares | 3,428,750 | |||||
Stock Issued During Period, Shares, Issued for Services | shares | 28,985 | 39,167 | ||||
Stock Issued During Period, Value, Issued for Services | $ 181,000 | $ 235,000 | ||||
Reverse Stock Split [Member] | ||||||
Stockholders' Equity Note, Stock Split, Conversion Ratio | 6 | 6 | ||||
Chairman and Chief Executive Officer [Member] | ||||||
Deferred Salary Settled by Shares | $ 1,100,000 | |||||
Common Stock Issued for Settlement of Deferred Salary Balance | shares | 233,734 | |||||
Gain (Loss) on Issuance of Common Stock | $ (83,807) | |||||
Several Investors, Including Acuitas and Shamus [Member] | Convertible Debentures [Member] | ||||||
Debt Conversion, Converted Instrument, Shares Issued | shares | 2,982,994 | |||||
Gain (Loss) on Conversion of Debt | $ (1,400,000) | |||||
Public Offering [Member] | Joseph Gunnar & Co., LLC [Member] | ||||||
Stock Issued During Period, Shares, New Issues | shares | 3,125,000 | |||||
Shares Issued, Price Per Share | $ / shares | $ 4.80 | |||||
Shares Issued, Price Per Share, Net | $ / shares | $ 4.464 | |||||
Proceeds from Issuance of Common Stock | $ 15,000,000 | |||||
Over-Allotment Option [Member] | Joseph Gunnar & Co., LLC [Member] | ||||||
Stock Issued During Period, Shares, New Issues | shares | 303,750 | |||||
Proceeds from Issuance of Common Stock | $ 1,500,000 | |||||
Additional Shares Available for Purchase | shares | 468,750 |
Note 7 - Share-based Compensa43
Note 7 - Share-based Compensation (Details Textual) - USD ($) | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Share-based Compensation | $ 465,000 | $ 697,000 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 1,700,000 | 0 |
Employees and Directors [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 1,674,864 | |
The 2017 Stock Incentive Plan [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 2,333,334 | |
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 10 years | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | 1,885,383 | |
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 691,804 | |
Share-based Compensation | $ 465,000 | $ 697,000 |
The 2017 Stock Incentive Plan [Member] | Employees and Directors [Member] | ||
Share-based Compensation | $ 465,000 | $ 697,000 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 1,674,864 | 0 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 2.32 | |
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized | $ 4,700,000 | |
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition | 4 years 83 days | |
The 2017 Stock Incentive Plan [Member] | Minimum [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 3 years | |
The 2017 Stock Incentive Plan [Member] | Maximum [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 5 years | |
The 2010 Stock Incentive Plan [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 243,853 |
Note 7 - Share-based Compensa44
Note 7 - Share-based Compensation - Employee and Director Stock Option Activity (Details) - $ / shares | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Granted, shares (in shares) | 1,700,000 | 0 |
Balance, shares (in shares) | 1,885,383 | |
Balance, weighted average exercise price (in dollars per share) | $ 11.43 | |
Exercisable, shares (in shares) | 306,612 | |
Exercisable, weighted average exercise price (in dollars per share) | $ 31.49 | |
Employees and Directors [Member] | ||
Balance, shares (in shares) | 244,046 | 245,213 |
Balance, weighted average exercise price (in dollars per share) | $ 38.94 | $ 39.06 |
Granted, shares (in shares) | 1,674,864 | |
Granted, weighted average exercise price (in dollars per share) | $ 7.50 | |
Cancelled/Expired, shares (in shares) | (33,527) | (1,167) |
Cancelled/Expired, weighted average exercise price (in dollars per share) | $ 14.54 | $ 67.86 |
Balance, shares (in shares) | 1,885,383 | 244,046 |
Balance, weighted average exercise price (in dollars per share) | $ 11.46 | $ 38.94 |
Exercisable, shares (in shares) | 306,612 | |
Exercisable, weighted average exercise price (in dollars per share) | $ 31.49 |
Note 7 - Share-based Compensa45
Note 7 - Share-based Compensation - Options by Exercise Price Range (Details) | 12 Months Ended |
Dec. 31, 2017$ / sharesshares | |
Options Outstanding Shares (in shares) | shares | 1,885,383 |
Options Outstanding Weighted Average Remaining Life (Year) | 8 years 229 days |
Options Outstanding Weighted Average Price (in dollars per share) | $ 11.43 |
Exercisable, shares (in shares) | shares | 306,612 |
Exercisable, weighted average exercise price (in dollars per share) | $ 31.49 |
Range One [Member] | |
Lower Exercise Price Limit (in dollars per share) | 0 |
Upper Exercise Price Limit (in dollars per share) | $ 110 |
Options Outstanding Shares (in shares) | shares | 1,883,839 |
Options Outstanding Weighted Average Remaining Life (Year) | 8 years 233 days |
Options Outstanding Weighted Average Price (in dollars per share) | $ 10.66 |
Exercisable, shares (in shares) | shares | 305,068 |
Exercisable, weighted average exercise price (in dollars per share) | $ 26.82 |
Range Two [Member] | |
Lower Exercise Price Limit (in dollars per share) | 110.01 |
Upper Exercise Price Limit (in dollars per share) | $ 1,500 |
Options Outstanding Shares (in shares) | shares | 1,544 |
Options Outstanding Weighted Average Remaining Life (Year) | 1 year 10 days |
Options Outstanding Weighted Average Price (in dollars per share) | $ 953.39 |
Exercisable, shares (in shares) | shares | 1,544 |
Exercisable, weighted average exercise price (in dollars per share) | $ 953.39 |
Note 7 - Share-based Compensa46
Note 7 - Share-based Compensation - Stock Options and Warrants Granted to Non-employees for Services Outstanding (Details) - $ / shares | 1 Months Ended | 12 Months Ended | |
Jun. 30, 2017 | Dec. 31, 2017 | Dec. 31, 2016 | |
Stock Options and Warrants Nonemployees [Member] | |||
Warrants Issued (in shares) | 698,168 | 1,026,017 | |
Warrants Issued Weighted Average Exercise Price (in dollars per share) | $ 4.91 | $ 4.80 | |
Issued in Connection With Equity Offering [Member] | Stock Options and Warrants Nonemployees [Member] | |||
Warrants Issued (in shares) | 156,250 | ||
Warrants Issued Weighted Average Exercise Price (in dollars per share) | $ 6 | ||
Issued in Connection With Debt Agreement [Member] | Stock Options and Warrants Nonemployees [Member] | |||
Warrants Issued (in shares) | 451,918 | 1,026,017 | |
Warrants Issued Weighted Average Exercise Price (in dollars per share) | $ 4.51 | $ 4.80 | |
Warrants Issued for Services [Member] | |||
Warrants Issued (in shares) | 90,000 | ||
Warrants Issued Weighted Average Exercise Price (in dollars per share) | $ 5 | ||
Warrants Issued for Services [Member] | Stock Options and Warrants Nonemployees [Member] | |||
Warrants Issued (in shares) | 90,000 | ||
Warrants Issued Weighted Average Exercise Price (in dollars per share) | $ 5 |
Note 8 - Commitments and Cont47
Note 8 - Commitments and Contingencies (Details Textual) | 12 Months Ended | |
Dec. 31, 2017USD ($)ft² | Dec. 31, 2016USD ($) | |
Operating Leases, Rent Expense, Net | $ 296,000 | $ 296,000 |
Principal Executive and Administrative Offices [Member] | ||
Area of Real Estate Property | ft² | 9,120 | |
Operating Lease Monthly Rent | $ 32,000 |
Note 8 - Commitments and Cont48
Note 8 - Commitments and Contingencies - Future Minimum Payments, Under Non-cancelable Operating Leases (Details) $ in Thousands | Dec. 31, 2017USD ($) |
2,018 | $ 387 |
2,019 | $ 99 |
Note 9 - Related Party Disclo49
Note 9 - Related Party Disclosure (Details Textual) - USD ($) | 1 Months Ended | 12 Months Ended | |||||
Apr. 30, 2017 | Mar. 31, 2017 | Jan. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2017 | Dec. 31, 2016 | Jul. 31, 2015 | |
Repayments of Convertible Debt | $ 4,363,000 | ||||||
Proceeds from Issuance of Common Stock | 16,458,000 | ||||||
Gain (Loss) on Issuance of Common Stock | (145,000) | ||||||
Due to Related Parties, Current | $ 9,796,000 | $ 9,796,000 | |||||
Amended Warrants [Member] | |||||||
Class of Warrant or Right, Number of Additional Securities Called by Each Warrant or Right | 0.2 | ||||||
Acuitas [Member] | Amended Warrants [Member] | |||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 31,167 | ||||||
Acuitas [Member] | July 2015 Convertible Debenture [Member] | |||||||
Debt Conversion, Original Debt, Amount | $ 4,300,000 | ||||||
Debt Conversion, Converted Instrument, Shares Issued | 2,385,111 | ||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||
Acuitas [Member] | Public Offering [Member] | |||||||
Stock Issued During Period, Shares, New Issues | 181,154 | ||||||
Proceeds from Issuance of Common Stock | $ 869,539 | ||||||
Acuitas [Member] | Amended Warrants [Member] | |||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 31,167 | ||||||
Acuitas [Member] | January 2017 Convertible Debenture [Member] | |||||||
Proceeds from Issuance of Debt | $ 1,300,000 | ||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 254,904 | ||||||
Repayments of Convertible Debt | 1,300,000 | ||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | ||||||
Chairman and Chief Executive Officer [Member] | |||||||
Deferred Salary Settled by Shares | $ 1,100,000 | ||||||
Common Stock Issued for Settlement of Deferred Salary Balance | 233,734 | ||||||
Gain (Loss) on Issuance of Common Stock | $ (83,807) | ||||||
Chairman and Chief Executive Officer [Member] | Travel and Expenses [Member] | |||||||
Due to Related Parties, Current | $ 254,000 | ||||||
Chairman and Chief Executive Officer [Member] | Acuitas [Member] | |||||||
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion | 100.00% | 75.00% | 75.00% | ||||
Shamus [Member] | Conversion Of December 2016 Convertible Debentures Into Common Stock [Member] | |||||||
Debt Conversion, Original Debt, Amount | $ 1,300,000 | ||||||
Debt Conversion, Converted Instrument, Shares Issued | 276,204 | ||||||
Shamus [Member] | Shamus Warrants [Member] | |||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 14,706 | ||||||
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion | 100.00% | 75.00% | 75.00% | ||||
Shamus [Member] | Acuitas [Member] | |||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 137,883 | ||||||
Shamus [Member] | December 2016 Convertible Debenture [Member] | |||||||
Proceeds from Issuance of Debt | $ 300,000 | $ 300,000 | |||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | 8.00% | |||||
Investors [Member] | December 2016 Convertible Debenture [Member] | |||||||
Repayments of Convertible Debt | $ 2,900,000 | ||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% |
Note 10 - Short-term Debt (Deta
Note 10 - Short-term Debt (Details Textual) - USD ($) | 1 Months Ended | 12 Months Ended | ||||||||||
Apr. 30, 2017 | Jan. 31, 2017 | Dec. 31, 2016 | Aug. 31, 2016 | Jul. 31, 2016 | Jun. 30, 2016 | May 31, 2016 | Apr. 30, 2016 | Mar. 31, 2016 | Dec. 31, 2017 | Dec. 31, 2016 | Mar. 31, 2017 | |
Proceeds from Related Party Debt | $ 5,505,000 | |||||||||||
Warrant Liabilities, Noncurrent | $ 5,307,000 | 30,000 | 5,307,000 | |||||||||
Repayments of Convertible Debt | 4,363,000 | |||||||||||
Amended Warrants [Member] | ||||||||||||
Warrant Liabilities, Noncurrent | 5,300,000 | 5,300,000 | ||||||||||
Class of Warrant or Right, Number of Additional Securities Called by Each Warrant or Right | 0.2 | |||||||||||
Write-off of Warrant Liability | $ 6,200,000 | |||||||||||
Warrants Not Subject to Amendment [Member] | ||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 11,049 | |||||||||||
Director [Member] | ||||||||||||
Warrant Term | 5 years | |||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 145,833 | |||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 6.60 | |||||||||||
Proceeds from Related Party Debt | $ 2,800,000 | |||||||||||
Investors [Member] | ||||||||||||
Debt Instrument, Face Amount | $ 5,600,000 | $ 5,600,000 | ||||||||||
Investors [Member] | December 2016 Warrants [Member] | ||||||||||||
Warrant Term | 5 years | |||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 6.60 | $ 6.60 | ||||||||||
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion | 40.00% | 40.00% | ||||||||||
Class of Warrant or Right, Issued During Period | 337,139 | 337,139 | ||||||||||
Shamus [Member] | Shamus Warrants [Member] | ||||||||||||
Warrant Term | 5 years | |||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 14,706 | |||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 5.10 | $ 5.10 | ||||||||||
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion | 100.00% | 75.00% | 75.00% | |||||||||
Class of Warrant or Right, Issued During Period | 44,118 | |||||||||||
Acuitas [Member] | December 2016 Warrants [Member] | ||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 137,883 | |||||||||||
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion | 25.00% | 25.00% | ||||||||||
Acuitas [Member] | Amended Warrants [Member] | ||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 31,167 | |||||||||||
Acuitas [Member] | January 2017 Warrants [Member] | ||||||||||||
Warrant Term | 5 years | |||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 5.10 | |||||||||||
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion | 100.00% | |||||||||||
Acuitas [Member] | ||||||||||||
Warrant Term | 5 years | 5 years | 5 years | 5 years | 5 years | |||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 338,005 | 71,970 | 60,606 | 51,136 | 33,333 | 75,000 | ||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 1.98 | $ 1.98 | $ 1.98 | $ 1.98 | $ 2.82 | $ 2.82 | ||||||
Class of Warrant or Right, Outstanding | 47,475 | 106,818 | ||||||||||
Acuitas [Member] | Exchange of Warrants [Member] | ||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 498,927 | |||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 6.60 | |||||||||||
Accredited Investor [Member] | Amended Warrants [Member] | ||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 13,258 | |||||||||||
April 2016 Promissory Note [Member] | Acuitas [Member] | ||||||||||||
Proceeds from Issuance of Debt | $ 400,000 | |||||||||||
Debt Instrument, Face Amount | 1,300,000 | |||||||||||
May 2016 Promissory Note [Member] | Acuitas [Member] | ||||||||||||
Proceeds from Issuance of Debt | $ 405,000 | |||||||||||
Debt Instrument, Face Amount | 1,700,000 | |||||||||||
June 2016 Promissory Notes [Member] | Acuitas [Member] | ||||||||||||
Proceeds from Issuance of Debt | $ 570,000 | $ 480,000 | ||||||||||
Debt Instrument, Face Amount | 2,800,000 | 2,200,000 | ||||||||||
Senior Promissory Note [Member] | Acuitas [Member] | Exchanged Senior Demand Notes [Member] | ||||||||||||
Debt Instrument, Face Amount | $ 2,800,000 | $ 2,800,000 | $ 2,800,000 | |||||||||
Debentures [Member] | Investors [Member] | ||||||||||||
Debt Instrument, Face Amount | $ 5,600,000 | |||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | 8.00% | 8.00% | |||||||||
Warrant Term | 5 years | |||||||||||
Debentures [Member] | Shamus [Member] | ||||||||||||
Warrant Term | 5 years | |||||||||||
December 2016 Convertible Debenture [Member] | Investors [Member] | ||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |||||||||||
Repayments of Convertible Debt | $ 2,900,000 | |||||||||||
December 2016 Convertible Debenture [Member] | Shamus [Member] | ||||||||||||
Proceeds from Issuance of Debt | $ 300,000 | $ 300,000 | ||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | 8.00% | ||||||||||
January 2017 Convertible Debenture [Member] | Acuitas [Member] | ||||||||||||
Proceeds from Issuance of Debt | $ 1,300,000 | |||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 254,904 | |||||||||||
Class of Warrant or Right, Issued During Period | 254,904 | |||||||||||
Repayments of Convertible Debt | $ 1,300,000 | |||||||||||
Acuitas [Member] | March 2016 Promissory Note [Member] | ||||||||||||
Proceeds from Issuance of Debt | $ 900,000 | |||||||||||
Debt Instrument, Face Amount | $ 900,000 | |||||||||||
Debt Instrument, Term | 30 days | |||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |||||||||||
Debt Instrument, Interest Rate, Stated Percentage After Maturity Date | 12.00% | |||||||||||
Acuitas [Member] | April 2016 Promissory Note [Member] | ||||||||||||
Proceeds from Issuance of Debt | 400,000 | |||||||||||
Debt Instrument, Face Amount | $ 1,300,000 | |||||||||||
Acuitas [Member] | May 2016 Promissory Note [Member] | ||||||||||||
Proceeds from Issuance of Debt | 405,000 | |||||||||||
Debt Instrument, Face Amount | $ 1,700,000 | |||||||||||
Acuitas [Member] | June 2016 Promissory Notes [Member] | ||||||||||||
Proceeds from Issuance of Debt | $ 570,000 | $ 480,000 |
Note 11 - Restatement of Fina51
Note 11 - Restatement of Financial Statements (Details Textual) | Apr. 25, 2017 | Dec. 31, 2017 |
Reverse Stock Split [Member] | ||
Stockholders' Equity Note, Stock Split, Conversion Ratio | 6 | 6 |